Your browser doesn't support javascript.
loading
Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal study.
Froklage, F E; Oosterbaan, L J; Sizoo, E M; de Groot, M; Bosma, I; Sanchez, E; Douw, L; Heimans, J J; Reijneveld, J C; Lagerwaard, F J; Buter, J; Uitdehaag, B M J; Klein, M; Postma, T J.
Affiliation
  • Froklage FE; Department of Neurology, SEIN-Epilepsy Institute in the Netherlands Foundation, Achterweg 5, 2103 SW, Heemstede, The Netherlands, f.froklage@vumc.nl.
J Neurooncol ; 116(2): 387-94, 2014 Jan.
Article in En | MEDLINE | ID: mdl-24264531

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Agents, Alkylating / Dacarbazine / Leukoencephalopathies / Glioma Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neurooncol Year: 2014 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Agents, Alkylating / Dacarbazine / Leukoencephalopathies / Glioma Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neurooncol Year: 2014 Document type: Article